UEMS Medical Specialty
Geriatrics & Longevity Medicine
Dossiers covering senolytic compounds, NAD⁺ precursor supplementation, cellular senescence, and evidence-based longevity medicine formulations.
15
dossiers
Cellular Longevity & Senolytics
Clock Gene Expression (CLOCK/BMAL1) Impact on Pharmacokinetics: Implications for Chrononutrition and Chronopharmacology
Current pharmaceutical and nutritional guidelines often neglect circadian rhythmicity, leading to suboptimal therapeutic efficacy and unpredictable pharmacokinetic profiles for molecular interventions. Integrating clock gene biology into dosing regimens requires precise understanding of ADME variations.
Post-GLP-1 Metabolic Optimization
Drug-Induced Nutrient Depletion (DIND): Molecular Mechanisms of Iatrogenic Deficiencies in Chronic Pharmacotherapy
Mitigating drug-induced nutrient depletion requires advanced CDMO solutions to formulate targeted nutritional support that is compatible with existing chronic pharmacotherapy and addresses diverse mechanistic pathways of depletion.
Post-GLP-1 Metabolic Optimization
Amino-Peptide Matrices for Lean Mass Preservation in GLP-1 Receptor Agonist-Induced Gastroparesis
GLP-1 RA-induced gastroparesis and retained gastric contents present a significant challenge for effective oral nutrition delivery and lean mass preservation during weight loss therapy, especially in at-risk populations.
Cellular Longevity & Senolytics
Immunometabolism, Active Resolution of Inflammation, and Specialized Pro-resolving Mediators (SPMs) from EPA/DHA
Current anti-inflammatory strategies often inhibit active resolution pathways, leading to chronic inflammation. Developing stable, bioavailable specialized pro-resolving mediators (SPMs) or modulators that enhance endogenous SPM biosynthesis without compromising resolution is a significant challenge.
Cellular Longevity & Senolytics
Targeted Mitochondrial Medicine: Synergistic Modulation of AMPK and NAD⁺ Salvage Pathways for Cardiometabolic Health
The challenge lies in developing stable, bioavailable, and synergistically effective combination formulations of NAD⁺ precursors and AMPK modulators to precisely target cellular bioenergetic decline in age-related cardiometabolic conditions.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis
Developing therapeutic interventions that modulate consciousness or psychiatric pathology requires targeting quantum-level phenomena within neuronal microtubules, posing a significant challenge for conventional drug design and delivery given the elusive nature of these mechanisms.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Quantum Physics and Medicine: A Review of Common Aspects
Integrating quantum phenomena, essential for advanced diagnostics and computation, into stable and functional biomedical devices for precise clinical application amidst complex biological environments presents a significant CDMO hurdle.
Microvascular Hemodynamics & Endothelial Integrity
Common Aspects of Quantum Physics and Phlebology: A Literature Review
Developing precise, wavelength-optimized laser ablation and advanced imaging modalities for phlebology requires deep understanding of photon-tissue interaction and complex quantum phenomena, posing significant engineering and material science hurdles for consistent clinical outcomes.
Cellular Longevity & Senolytics
Cellular Senescence, SASP, and Senolytic Targeting of Age-Related Pathologies
Delivering senolytics effectively to specific senescent cell populations and overcoming their multi-pathway pro-survival redundancy (SCAPs) without off-target effects remains a significant challenge for therapeutic development.
Cellular Longevity & Senolytics
BCS Class IV Senolytics: Nano-Micellar Flavonoid Delivery for Targeted Senescence Clearance
Hydrophobic senolytic flavonoids like fisetin and quercetin face significant bioavailability challenges due to poor aqueous solubility, limiting their therapeutic potential. Conventional formulations fail to achieve adequate systemic exposure for effective cellular senescence clearance.
Cellular Longevity & Senolytics
Thermodynamic Stability and Degradation Kinetics of Thermolabile Longevity Compounds Under High-Shear Manufacturing Stress
Thermolabile longevity-associated compounds face significant thermal, oxidative, pH, and mechanical stresses during high-shear manufacturing processes. These combined stressors accelerate chemical degradation, leading to reduced delivered potency and efficacy.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Diet-Specified Interventions in Neurodegenerative Disease Mechanisms
Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.
Intracellular Defense & IV-Alternatives
Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies
Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.
Cellular Longevity & Senolytics
Synergistic Modulation of Cellular Senescence Biomarkers by Target-Specific Nutraceutical Matrices
Developing a nutraceutical matrix that precisely modulates senescence-related biomarkers requires integrating senolytic activity, SASP suppression, and mitochondrial restoration within a single formulation while ensuring in vitro reproducibility and scalability.
Cellular Longevity & Senolytics
Comparative Pharmacokinetics and Cellular Bioaccessibility of Senolytic Agents: Impact of Polymeric-Matrix Encapsulation
Orally administered senolytic compounds often suffer from poor pharmacokinetics, including low and variable bioavailability, rapid metabolism, pH-dependent dissolution, and limited cellular bioaccessibility.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.